Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix
Clinical trial NCT06771596 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06771596
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2025-07-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.